Effect of Chromium Supplementation on Element Distribution in a Mouse Model of Polycystic Ovary Syndrome

Biological Trace Element Research

Volumn 168, Issue 2, 2015, Pages 472-480

  Chen, Tsung Sheng ^a   Chen, Yi Ting ^a   Liu, Chia Hsin ^b   Sun, Chi Ching ^b   Mao, Frank Chiahung ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b Department of Research and Development   (Taiwan)

Author keywords

Chromium; Copper; Insulin resistance; Iron; Polycystic ovary syndrome; Zinc

Indexed keywords

BIOLOGICAL MARKER; CHROMIUM; COPPER; ELEMENT; IRON; PLACEBO; PRASTERONE; ZINC; GLUCOSE BLOOD LEVEL; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOVULATION; ARTICLE; BONE LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FEMALE INFERTILITY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; METABOLIC BALANCE; METAL METABOLISM; MILK; MINERAL BLOOD LEVEL; MINERAL SUPPLEMENTATION; MOUSE; MOUSE MODEL; MUSCLE LEVEL; NONHUMAN; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; ABDOMINAL FAT; ANALYSIS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BONE; DIET; DIETARY SUPPLEMENT; DISEASE MODEL; LIVER; METABOLISM; OVARY; POLYCYSTIC OVARY SYNDROME; SKELETAL MUSCLE;

ABDOMINAL FAT; ANIMALS; BIOMARKERS; BLOOD GLUCOSE; BONE AND BONES; CHROMIUM; COPPER; DIET; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; INSULIN; INSULIN RESISTANCE; IRON; LIVER; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; OVARY; POLYCYSTIC OVARY SYNDROME; ZINC;

EID: 84947035269     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-015-0384-6     Document Type: Article

References (68)

1. Boyle J, Teede HJ (2012) Polycystic ovary syndrome-an update. Aust Fam Physician 41:752–756
2. Hung JH, Hu LY, Tsai SJ et al (2014) Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One 9:e97041
3. March WA, Moore VM, Willson KJ et al (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25:544–551
4. Sirmans SM, Pate KA (2014) Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 6:1–13
5. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2014) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47
6. Zawadzki JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR (eds) Polycystic ovary syndrome. Blackwell Scientific, Boston, pp 377–384
7. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774–800
8. Welt CK, Duran JM (2014) Genetics of polycystic ovary syndrome. Semin Reprod Med 32:177–182
9. Chen WY, Chen CJ, Liu CH et al (2009) Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab 11:293–303
10. Chen WY, Chen CJ, Liao JW et al (2009) Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sci 84:606–614
11. Amooee S, Parsanezhad ME, Ravanbod Shirazi M et al (2013) Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial. Iran J Reprod Med 11:611–618
12. Flores CR, Puga MP, Wrobel K et al (2011) Trace elements status in diabetes mellitus type 2: possible role of the interaction between molybdenum and copper in the progress of typical complications. Diabetes Res Clin Pract 91(3):333–341
13. Viktorínová A, Toserová E, Krizko M et al (2009) Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 58(10):1477–1482
14. Xu J, Zhou Q, Liu G et al (2013) Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications. Oxid Med Cell Longev 2013:635214
15. Celik C, Bastu E, Abali R et al (2013) The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome. Gynecol Endocrinol 29(5):488–491
16. Chakraborty P, Ghosh S, Goswami SK et al (2013) Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome. Biol Trace Elem Res 152:9–15
17. Zheng G, Wang L, Guo Z et al. (2015) Association of serum heavy metals and trace element concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population. Biol Trace Elem Res (epub ahead of print)
18. Kurdoglu Z, Kurdoglu M, Demir H et al (2012) Serum trace elements and heavy metals in polycystic ovary syndrome. Hum Exp Toxicol 31:452–456
19. Beletate V, El Dib R, Atallah ÁN (2007) Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 1:CD005525
20. Foroozanfard F, Jamilian M, Jafari Z et al (2015) Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes 123(4):215–220
21. Pourteymour Fard Tabrizi F, Alipoor B, Sadagiani M et al (2010) Effect of zinc supplementation on cardiometabolic risk factors in women with polycystic ovary syndrome. J Cardiovasc Thorac Res 2:11–20
22. Guler I, Himmetoglu O, Turp A et al (2014) Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance. Biol Trace Elem Res 158(3):297–304
23. Noda Y, Ota K, Shirasawa T et al (2012) Copper/zinc superoxide dismutase insufficiency impairs progesterone secretion and fertility in female mice. Biol Reprod 86(1):1–8
24. Ho YS, Gargano M, Cao J et al (1998) Reduced fertility in female mice lacking copper-zinc superoxide dismutase. J Biol Chem 273(13):7765–7769
25. Escobar-Morreale HF (2012) Iron metabolism and the polycystic ovary syndrome. Trends Endocrinol Metab 23:509–515
26. Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI et al (2007) Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care 30(9):2309–2313
27. Sam AH, Busbridge M, Amin A et al (2013) Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabet Med 30(12):1495–1499
28. Luque-Ramírez M, Álvarez-Blasco F, Alpañés M et al (2011) Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. J Clin Endocrinol Metab 96(3):846–852
29. Kim JW, Kang KM, Yoon TK et al (2014) Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome. Fertil Steril 102(2):548–554
30. Turner-McGrievy G, Davidson CR, Billings DL (2015) Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive. Hum Fertil (Camb) 18(1):16–21
31. Anderson RA (1997) Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol 26(1 Pt 2):S35–S41
32. Mertz W (1993) Chromium in human nutrition: a review. J Nutr 123(4):626–633
33. Di Bona KR, Love S, Rhodes NR et al (2011) Chromium is not an essential trace element for mammals: effects of a “low-chromium” diet. J Biol Inorg Chem 16(3):381–390
34. Vincent JB (2015) Is the pharmacological mode of action of chromium (III) as a second messenger? Biol Trace Elem Res (epub ahead of print)
35. Yoshida M (2012) Is chromium an essential trace element in human nutrition? Nihon Eiseigaku Zasshi 67(4):485–491
36. Król E, Krejpcio Z, Michalak S et al (2012) Effects of combined dietary chromium(III) propionate complex and thiamine supplementation on insulin sensitivity, blood biochemical indices, and mineral levels in high-fructose-fed rats. Biol Trace Elem Res 150(1–3):350–359
37. Vincent JB (2013) Chromium: is it essential, pharmacologically relevant, or toxic? Met Ions Life Sci 13:171–198
38. Pei D, Hsieh CH, Hung YJ et al (2006) The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 55:923–927
39. Chen YL, Lin JD, Hsia TL et al (2014) The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes. Eur J Nutr 53:127–133
40. Staniek H, Rhodes NR, Di Bona KR et al (2013) Comparison of tissue metal concentrations in Zucker lean, Zucker obese, and Zucker diabetic fatty rats and the effects of chromium supplementation on tissue metal concentrations. Biol Trace Elem Res 151(3):373–383
41. Lucidi RS, Thyer AC, Easton CA et al (2005) Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome. Fertil Steril 84:1755–1757
42. Lydic ML, McNurlan M, Bembo S et al (2006) Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome. Fertil Steril 86(1):243–246
43. Vincent JB (2013) The bioinorganic chemistry of chromium(III). Wiley, Chichester
44. Amr N, Abdel-Rahim HE (2015) The effect of chromium supplementation on polycystic ovary syndrome in adolescents. J Pediatr Adolesc Gynecol 28(2):114–118
45. Solano ME, Sander VA, Ho H et al (2011) Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS). J Reprod Immunol 92:33–44
46. Chen PW, Lin C, Chen CD et al (2013) Chromium levels in insulin-sensitive tissues and the thigh bone are modulated by prednisolone and high-fat diets in mice. Biometals 26:347–354
47. Lin C, Chen P, Chen W et al (2013) Glucagon and insulin have opposite effects on tissue chromium distribution in an obese mouse model. J Diabetes Investig 4:528–532
48. Dowling AR, Nedorezov LB, Qiu X et al (2013) Genetic factors modulate the impact of pubertal androgen excess on insulin sensitivity and fertility. PLoS ONE 8:e79849
49. van Houten EL, Visser JA (2014) Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function? Reprod Biol 14:32–43
50. Sharifi F, Nasab NM, Zadeh HJ (2008) Elevated serum ferritin concentrations in prediabetic subjects. Diab Vasc Dis Res 5:15–18
51. Bennett R, Adams B, French A et al (2006) High-dose chromium(III) supplementation has no effects on body mass and composition while altering plasma hormone and triglycerides concentrations. Biol Trace Elem Res 113(1):53–66
52. Sohrabvand F, Shirazi M, Shariat M et al (2013) Serum zinc level in infertile women with and without polycystic ovary syndrome: a comparative study. Tehran Univ Med 71:157–163
53. Lim TH, Sargent T III, Kusubov N (1983) Kinetics of trace element chromium(III) in the human body. Am J Physiol 244:R445–R454
54. Ibricevic D, Asimi ZV (2013) Frequency of prediabetes in women with polycystic ovary syndrome. Med Arch 67:282–285
55. Rafiei R, Habyby Z, Fouladi L et al (2014) Chromium level in prediction of diabetes in pre-diabetic patients. Adv Biomed Res 3:235
56. Kottwitz K, Laschinsky N, Fischer R et al (2009) Absorption, excretion and retention of 51Cr from labelled Cr-(III)-picolinate in rats. Biometals 22(2):289–295
57. Vincent JB (2000) The biochemistry of chromium. J Nutr 130(4):715–718
58. Campbell WW, Beard JL, Joseph LJ (1997) Chromium picolinate supplementation and resistive training by older men: effects on iron-status and hematologic indexes. Am J Clin Nutr 66:944–949
59. Lukaski HC, Siders WA, Penland JG (2007) Chromium picolinate supplementation in women: effects on body weight, composition, and iron status. Nutrition 23:187–195
60. Tawfeeq FR, Abbas MR, Abdul Kareem Y (2008) Serum copper, zinc and Cu/Zn ratio in diabetics. Iraqi J Comm Med 21:64–68
61. Zheng Y, Li XK, Wang Y et al (2008) The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators. Hemoglobin 32(1–2):135–145
62. González F, Rote NS, Minium J et al (2006) Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91(1):336–340
63. Kelly CC, Lyall H, Petrie JR et al (2001) Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 86(6):2453–2455
64. Gaier ED, Kleppinger A, Ralle M et al (2012) High serum Cu and Cu/Zn ratios correlate with impairments in bone density, physical performance and overall health in a population of elderly men with frailty characteristics. Exp Gerontol 47(7):491–496
65. Malavolta M, Giacconi R, Piacenza F et al (2010) Plasma copper/zinc ratio: an inflammatory /nutritional biomarker as predictor of all-cause mortality in elderly population. Biogerontology 11(3):309–319
66. Guo CH, Chen PC, Yeh MS et al (2011) Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem 44(4):275–280
67. Shrivastava R, Upreti RK, Seth PK et al (2002) Effects of chromium on the immune system. FEMS Immunol Med Microbiol 34(1):1–7
68. Walters KA, Allan CM, Handelsman DJ (2012) Rodent models for human polycystic ovary syndrome. Biol Reprod 86(149):11–12